Who We Serve

Serving all segments of pharma and MD&D manufacturers

Marbls partners with life sciences companies, from emerging biotech to leading pharma and MD&D manufacturers. As an international consultancy, we provide practical services and advisory that address our clients complex market and operational challenges in the US, Europe and beyond.

Mid and Large Pharma

Medical Device

Generics

Emerging Pharma

Medical Diagnostics

BioTech

Our service philosophy & sectors we serve

At Marbls, the success of our clients comes first.

We believe great relationships facilitate exceptional results. With 20 years in life sciences, we’ve seen the impact of the work we do with our clients to bring life-changing drugs, devices and diagnostics to market — and improve individual and public health. We’re inspired by the work of our clients and are dedicated to delivering on our promises to support global programs and innovative technology solutions. Together, we address the complex dynamics of today’s market in ways that create sustainable growth and improve efficiencies in manufacturers processes.

A Case Study in Pharma

CS1_art1
CS1_art2
CS1_art3

Planning and execution for an emerging biotech’s first drug launch

The Challenge

Marbls was chosen by an emerging American biotech to launch the company’s first drug, and facilitate readiness of commercial and governmental contracting functions. Activities included such key areas as:

  • Contract management of payors and providers
  • Administration of chargebacks, rebates and admin fees
  • Statutory reporting requirements for government
  • Management and adjudication of state Medicaid programs

Problem Statement: Our client had a PDUFA date in six months with an anticipated launch in nine months, lending an urgency to the engagement. With a lean market access team just starting operational planning, the client anticipated outsourcing key commercial and government contracting functions to an outside provider which required:

  • Services to support assessment, evaluation and recommendation towards a chosen provider
  • A detailed plan and roadmap towards launch readiness

The Solution

Drawing on our advisory and commercial excellence expertise, our teams took a three-phase approach to plan and launch our client’s first drug launch.

1. Assessment
Reviewed the organization in detail including upcoming hires, external stakeholders supporting the company and assessed market access, contracting and channel strategies for the companies lead compound

Produced a launch requirements document detailing processes, data and technology required to support launch activities

2. Evaluation
Provided a market overview and assessment of different business process outsource (BPO) providers

Developed a formal request for proposal (RFP) document and conducted the search and review process with vendors

Scored the vendors with the company using objective methodology to assess key parameters such as:

  • Capabilities and fit to requirements
  • Organizational and solution maturity
  • Security and automation to support data
  • Reporting and Analytics capabilities
  • Cost for setup along with ongoing fees

3. Recommendation
Our teams determined a vendor that could support all process areas in scope and began the contractual process

Impact
Developed an onboarding plan and roadmap to support immediate launch and ongoing operations for all process areas in scope

Marbls was asked to further provide services for the company for their launch period immediately following vendor selection

Case Study in Medical Device & Diagnostics

Implementing Model N for a global medical device company through an accelerated approach and timeline

CS2_art1
CS2_art2
CS2_art3

The Challenge

Marbls was chosen by a global medical device company with a presence in the midwestern US to facilitate implementation of Model N. Prior to implementation, pricing and contracting processes between the company and its customers were performed manually and supported by various technologies, such as ERP, EDI, and Salesforce. These processes led to operational challenges and potential revenue leakage related to inaccurate pricing and rebate overpayments to certain end customers. The company also faced potential risk with government compliance.

Problem Statement: To improve and automate many of its manual processes, the company needed to implement the Model N Revenue Cloud Provider Management and Intelligence tool along with the Salesforce based module Deal Management on an accelerated timeline of nine months.

 
 

The Solution

Marbls engaged in work streams for both deal management and revenue management, all under one program and timeline.

Revenue Management Workstream: Due to multiple integration points and the associated complexity, Marbls utilized a waterfall approach with phases to capture requirements, define system design and configure/develop application and interfaces.

Deal Management Workstream: Structured inception, elaboration, and construction activities into Sprint cycles. Each sprint included a period of grooming, planning, execution and demonstration and review.

Impact
Automated the following processes:

  • Management of list and contract prices
  • Processing and validation of distributor rebates/chargebacks and other types of rebates, resulting in avoiding overpaying distributors and other end customers

Provided increased capabilities to track contract performance, resulting in implementation of mechanisms to track, measure, and report on customers who were not meeting their commitments

Integrated the Model N software into the company’s environment by working with their IT teams to fully integrate Model N with their specific systems (e.g., SAP, EDI and Salesforce)